Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Yizhuang Wu"'
Autor:
Yubao Guan, Daoyuan Wang, Xin Xu, Wenlong Shao, Baoliang Zhong, Haihong Yang, Steven Tucker, Jianxing He, Yizhuang Wu, Nanshan Zhong, Mei Jiang, Weiqiang Ying
Publikováno v:
Anti-Cancer Drugs. 20:838-844
Para-toluenesulfonamide (PTS), active ingredient being PTS, is a new anticancer drug applied through local intratumoral injection. The aim of this phase II clinical trial was to investigate the response and toxicity of standard gemcitabine (GEM) plus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff0426572f7d5fd102c06635b147c39a
https://doi.org/10.1097/cad.0b013e32832fe48f
https://doi.org/10.1097/cad.0b013e32832fe48f
Autor:
Yang, Gao, Yonghua, Gao, Weijie, Guan, Liyan, Huang, Xiaoming, Xu, Chenting, Zhang, Xiuqing, Chen, Yizhuang, Wu, Guangqiao, Zeng, Nanshan, Zhong
Publikováno v:
Journal of thoracic disease. 5(4)
Conventional chemotherapy and radiation therapy against non-small cell lung cancer (NSCLC) are relatively insensitive and unsatisfactory. Para-toluenesulfonamide (PTS), a unique antitumor drug for local intratumoral injection, shows an efficacy of se
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::033fd0b1f0c55ea77aa1f0c4c88f7fc2
https://pubmed.ncbi.nlm.nih.gov/23991305
https://pubmed.ncbi.nlm.nih.gov/23991305